What do you offer in pts with severe intracranial stenosis and recurrent cerebrovascular events, despite maximum medical management? Finally, the BASIS Chinese trial offers some options.
Submaximal balloon angioplasty (alone, without stenting) may be better than continuing medical management
[Balloon angioplasty vs medical management for intracranial artery stenosis: the BASIS randomized clinical trial. JAMA. 2024;332:1059–1069]
ICYMI: Check out August #Stroke#EditorPick: #OPTIMAS trial finds that chronic kidney disease does not modify the effects of early versus delayed DOAC initiation after acute ischemic stroke. #AHAJournals
https://t.co/9oXKCgFtux
Don't miss this Global Stroke Action Coalition launch event to explore stroke-focused policy interventions to accelerate progress on global NCD targets ahead of the United Nation HLM on NCDs later this year.
Register TODAY https://t.co/xTwGJuAZqA
#StrokeActionNow
🌟Ep. 3 of our #MindfulMedicine series is here & this time we’re diving into the crucial topic of #Nutrition for #HCPs with practical tips on fueling mind & body🍽️
🔗And it’s a special video edition! https://t.co/szwGz06VSG
🎙️with @laura_wsa, @AnaFightStroke & @MichelleTheRD
#MondayTip
Key studies on #DOAC vs VKA in CVT
🧠Several observational studies and small but important RCTs have evaluated the efficacy and safety of DOACs as an alternative to VKAs in Cerebral Venous Thrombosis
✅Results support DOACs as a reasonable treatment option
New Educational Program for Stroke Centers in Spanish!
Thank you @CaMaLeOn_ictus and @juankalleja for the organization and moderation!
Thank you for all speakers!
🔥 CATALYST 🔥
👉🏻individual patient data meta analysis
👉🏻DOAC resumption after AIS
👉🏻early <4d vs late >=5d
👉🏻early 💊<1 outcome < AIS without >sICH
#WSC2024@DavidSeiffge@interneurona@ShadiYaghi2 @WorlStrokeOrg @SposatoL
#MondayTip
🧠In cardioembolic stroke we must look for the best moment to start anticoagulation combining the #lower risk of hemorrhagic #transformation and ischemic #recurrence ⚖️
👉Individualized strategy to start anticoagulation post EVT
(created from https://t.co/8h86RnC1Cd)
‼️Amigos y colegas‼️
🤩Con mucha alegría desde el Comité de Investigación los invitamos a difundir y participar del:
🧠Programa de #Mentoría de #Investigación en ECV LATAM Junior #Research ALATAC
📜Bases: https://t.co/3HIVnGa9BH
✍️Inscripciones: https://t.co/15at8u4xii
Article Commentary: “Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage” https://t.co/BU5x1lKaMN
In this #BloggingStroke post, Mitch Wilson discusses #Stroke topical review by @BleedingStroke & @SMGreenbergNeur.
🧠MRI features of Cerebral Amyloid Angiopathy - v3.0
🩸 Hemorrhagic (Left)
🌂Non-hemorrhagic (Right)
✴️ Denotes core markers included in Boston Criteria
(Bringing this schematic to spotlight again!)
#NeuroTwitter#NeuroRad#Neurology#neuropath#stroke#dementia#Alzheimers #biomarker #brain #MedStudentTwitter #AmyloidAngiopathy #CAA #cSVD
Now two stentretrievers required⁉️Twin2Win RCT, stopped early, shows superiority for reperfusion! #ISC24 Great study from@marcriboj @esmintsociety @DGNR_org
6/
📢We conclude:
👉 Patients with acute ischemic stroke treated with IVT in recent DOAC versus non‐DOAC use have similar rates of hemorrhagic complications and functional independence.
Close 🧵 Stay tuned for more!
5/
Additionally, the incidence of sICH demonstrated no significant variation between patients who had undergone idarucizumab administration (antidote) before intravenous thrombolysis and those who had not received it.
#MondayTip
☝️Myocardial injury is related to AIS even without prior cardiac disease, also called the #stroke_heart syndrome
🧠Acute lesions of the central autonomic network, especially the right hemispheric insula, are associated with an impaired LVEF🫀
https://t.co/3nvO3Epp1I